Cargando…
A Clinico-Epidemiological Study of Neurofibromatosis Type 1 and Its Relation to Quality of Life: A Cross-Sectional Study From India
Introduction: Neurofibromatosis type 1 (NF1) is an inherited neuroectodermal abnormality with multisystem effects, which can have heavy psychological and physical burdens, especially in countries like India, wherein skin disease is significantly stigmatized. This study was performed to understand th...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940560/ https://www.ncbi.nlm.nih.gov/pubmed/35371718 http://dx.doi.org/10.7759/cureus.22376 |
_version_ | 1784672951701864448 |
---|---|
author | Mahajan, Aditi Patvekar, Milind Lote, Samruddhi Deora, Mahendra Singh Poulose, Divya Gogineni, Jaya Madhurya Panikar, Krish Chaklader, Biswajit |
author_facet | Mahajan, Aditi Patvekar, Milind Lote, Samruddhi Deora, Mahendra Singh Poulose, Divya Gogineni, Jaya Madhurya Panikar, Krish Chaklader, Biswajit |
author_sort | Mahajan, Aditi |
collection | PubMed |
description | Introduction: Neurofibromatosis type 1 (NF1) is an inherited neuroectodermal abnormality with multisystem effects, which can have heavy psychological and physical burdens, especially in countries like India, wherein skin disease is significantly stigmatized. This study was performed to understand the clinical and epidemiological trends of NF1 at a tertiary care center in India and evaluate the association between clinical severity and quality of life in these patients. Methods: We conducted a cross-sectional study of 40 patients with NF1 over a period of two years at a tertiary hospital in western India. After obtaining consent, demographic and clinical information was collected from the patients and recorded in a pre-designed proforma. Quality of life was assessed by a validated Dermatology Life Quality Index (DLQI) questionnaire in languages understood by the patients and subsequently analyzed. Results: This study included 40 patients at a mean age of 28.6 years, with a slight male predominance. The most frequently occurring lesions were café-au-lait macules, followed by neurofibromas and intertriginous freckling. The mean DLQI score was 12.35, implying a large effect on most patients' lives. Questions related to self-consciousness, embarrassment, and the influence of skin lesions on clothing choices had the highest scores, indicating a significant effect on social perception. Conclusion: NF1 has a profound impact on a patient’s quality of life, as evidenced by the high DLQI scores in our patient cohort. The early identification and management of such patients can help prevent further deterioration of their quality of life. |
format | Online Article Text |
id | pubmed-8940560 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-89405602022-03-31 A Clinico-Epidemiological Study of Neurofibromatosis Type 1 and Its Relation to Quality of Life: A Cross-Sectional Study From India Mahajan, Aditi Patvekar, Milind Lote, Samruddhi Deora, Mahendra Singh Poulose, Divya Gogineni, Jaya Madhurya Panikar, Krish Chaklader, Biswajit Cureus Dermatology Introduction: Neurofibromatosis type 1 (NF1) is an inherited neuroectodermal abnormality with multisystem effects, which can have heavy psychological and physical burdens, especially in countries like India, wherein skin disease is significantly stigmatized. This study was performed to understand the clinical and epidemiological trends of NF1 at a tertiary care center in India and evaluate the association between clinical severity and quality of life in these patients. Methods: We conducted a cross-sectional study of 40 patients with NF1 over a period of two years at a tertiary hospital in western India. After obtaining consent, demographic and clinical information was collected from the patients and recorded in a pre-designed proforma. Quality of life was assessed by a validated Dermatology Life Quality Index (DLQI) questionnaire in languages understood by the patients and subsequently analyzed. Results: This study included 40 patients at a mean age of 28.6 years, with a slight male predominance. The most frequently occurring lesions were café-au-lait macules, followed by neurofibromas and intertriginous freckling. The mean DLQI score was 12.35, implying a large effect on most patients' lives. Questions related to self-consciousness, embarrassment, and the influence of skin lesions on clothing choices had the highest scores, indicating a significant effect on social perception. Conclusion: NF1 has a profound impact on a patient’s quality of life, as evidenced by the high DLQI scores in our patient cohort. The early identification and management of such patients can help prevent further deterioration of their quality of life. Cureus 2022-02-19 /pmc/articles/PMC8940560/ /pubmed/35371718 http://dx.doi.org/10.7759/cureus.22376 Text en Copyright © 2022, Mahajan et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Dermatology Mahajan, Aditi Patvekar, Milind Lote, Samruddhi Deora, Mahendra Singh Poulose, Divya Gogineni, Jaya Madhurya Panikar, Krish Chaklader, Biswajit A Clinico-Epidemiological Study of Neurofibromatosis Type 1 and Its Relation to Quality of Life: A Cross-Sectional Study From India |
title | A Clinico-Epidemiological Study of Neurofibromatosis Type 1 and Its Relation to Quality of Life: A Cross-Sectional Study From India |
title_full | A Clinico-Epidemiological Study of Neurofibromatosis Type 1 and Its Relation to Quality of Life: A Cross-Sectional Study From India |
title_fullStr | A Clinico-Epidemiological Study of Neurofibromatosis Type 1 and Its Relation to Quality of Life: A Cross-Sectional Study From India |
title_full_unstemmed | A Clinico-Epidemiological Study of Neurofibromatosis Type 1 and Its Relation to Quality of Life: A Cross-Sectional Study From India |
title_short | A Clinico-Epidemiological Study of Neurofibromatosis Type 1 and Its Relation to Quality of Life: A Cross-Sectional Study From India |
title_sort | clinico-epidemiological study of neurofibromatosis type 1 and its relation to quality of life: a cross-sectional study from india |
topic | Dermatology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940560/ https://www.ncbi.nlm.nih.gov/pubmed/35371718 http://dx.doi.org/10.7759/cureus.22376 |
work_keys_str_mv | AT mahajanaditi aclinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia AT patvekarmilind aclinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia AT lotesamruddhi aclinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia AT deoramahendrasingh aclinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia AT poulosedivya aclinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia AT goginenijayamadhurya aclinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia AT panikarkrish aclinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia AT chakladerbiswajit aclinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia AT mahajanaditi clinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia AT patvekarmilind clinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia AT lotesamruddhi clinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia AT deoramahendrasingh clinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia AT poulosedivya clinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia AT goginenijayamadhurya clinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia AT panikarkrish clinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia AT chakladerbiswajit clinicoepidemiologicalstudyofneurofibromatosistype1anditsrelationtoqualityoflifeacrosssectionalstudyfromindia |